Marchand J, Gouëzec H
Unité de sécurité transfusionnelle et d'hémovigilance, CHU de Rennes, Pontchaillou, France.
Transfus Clin Biol. 2005 Jun;12(2):180-5. doi: 10.1016/j.tracli.2005.04.013.
The publication of the Circular DGS/DHO/Afssaps N(o) 2003-582 of the December 15 2003 relating to the administration of blood and blood components, means that an update of statutory requirements is needed. This article presents the overall process from the writing of prescriptions to the care and monitoring of the transfused patient. An update and a critical analysis of regulations currently in force are presented for each step as well as a description of the main adverse events.
2003年12月15日发布的DGS/DHO/Afssaps第2003 - 582号通知,内容涉及血液及血液成分的管理,这意味着需要对法定要求进行更新。本文介绍了从开具处方到对输血患者进行护理和监测的整个过程。针对每个步骤,都给出了对现行法规的更新及批判性分析,以及主要不良事件的描述。